In this blog, Andrew Bridenstine discusses the rise in defamation produced by Artificial Intelligence. Andrew addresses the effects of these false statements on individuals. He argues that the defamation statute should be updated to hold AI companies liable for the misinformation generated by their algorithmic outputs.
Expanding Common Law Defamation to Address AI-Generated Falsehoods
In this article, Tom discusses how AI deepfakes pose a novel issue in United States political discourse and create new risks for reputation and public trust. Tom explores how AI deepfakes could fit into the current common law defamation framework and how AI deepfakes could be considered a “statement of fact.”
Betting on Your Data: How Gambling Apps Exploit Privacy Gaps
In this article, Wil explores the rise of gambling apps and the data privacy gaps that consumers face. He considers the legal implications of the privacy gaps within the industry and the potential for reform.
From Clinics to Chatbots: How Congress Can Protect Sensitive Information on AI Sites
In this blog, Tom explores how more people are turning to AI chatbots for mental-health support, and how the gap in federal privacy protections is growing. He argues for a HIPAA-inspired framework to ensure user data remains secure in the age of AI.
Plugging the Privacy Gap: How the FTC Can Protect Consumer Personal Data
In this blog, Wil explores the insufficiency of current privacy law under HIPAA, the FTC, and the HBNR. He then considers a potential solution to close the privacy gaps—incorporating all health apps under the HBNR with mandatory safeguards.
From Lab to Patent Office: The Journey of Synthetic Organisms through Intellectual Property Law
In this blog, Lana El-Etr examines the legal and ethical implications of patenting fully synthetic minimal cells, organisms engineered with only the essential genes for life. While a few Supreme Court decisions provide some guidance, this blog argues for updated patent standards that clearly define what qualifies as synthetic and patentable, guard against monopolization of foundational biological tools, and promote equitable access to medical and biotechnological advancements.